The findings of the study conducted by Li et al. involving 134 patients with T2D showed that individuals receiving a combination of ACB and insulin experienced a greater decrease in TNF-α levels compared with the group receiving insulin alone (151). This evidence concerns the gene TNF and type 2 diabetes mellitus.